Yuqin Song

机构：Peking University, Peking University Cancer Hospital, Ministry of Education · ORCID：0000-0002-5118-0625

发表论文 135 篇 · 总被引 1010 次 · h-index 18

代表论文

• Global burden and trends of hematologic malignancies based on Global Cancer Observatory 2022 and Global Burden of Disease 2021 (2025 · Experimental Hematology and Oncology · 被引 44)
• Lighting up arginine metabolism reveals its functional diversity in physiology and pathology (2024 · Cell Metabolism · 被引 33)
• SKYGLO: A Global Phase III Randomized Study Evaluating Glofitamab Plus Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients with Large B-Cell Lymphoma (LBCL) (2024 · Blood · 被引 19)
• Five-Year Analysis of the POLARIX Study: Prolonged Follow-up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) on Outcomes (2024 · Blood · 被引 18)
• EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma (2025 · Cell Death and Disease · 被引 5)
• Lighting up arginine metabolism reveals its functional diversity in physiology and pathology (2025 · Cell Metabolism · 被引 2)